Literature DB >> 17460365

Chymase and matrix metalloproteinase.

Hidenori Urata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17460365     DOI： 10.1291/hypres.30.3

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  7 in total

Review 1.  Intracrine angiotensin II functions originate from noncanonical pathways in the human heart.

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Jasmina Varagic; Che Ping Cheng; Leanne Groban; Hao Wang; James F Collawn; Louis J Dell Italia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-27       Impact factor: 4.733

Review 2.  The multiple mechanistic faces of a pure volume overload: implications for therapy.

Authors:  Justin Barnes; Louis J DellʼItalia
Journal:  Am J Med Sci       Date:  2014-10       Impact factor: 2.378

Review 3.  Mast cell chymase: morphofunctional characteristics.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2019-08-08       Impact factor: 4.304

Review 4.  Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018).

Authors:  Sarfaraz Ahmad; Carlos M Ferrario
Journal:  Expert Opin Ther Pat       Date:  2018-10-10       Impact factor: 6.674

5.  Increased fibroblast chymase production mediates procollagen autophagic digestion in volume overload.

Authors:  Lianwu Fu; Chih-Chang Wei; Pamela C Powell; Wayne E Bradley; Sarfaraz Ahmad; Carlos M Ferrario; James F Collawn; Louis J Dell'Italia
Journal:  J Mol Cell Cardiol       Date:  2016-01-22       Impact factor: 5.000

Review 6.  Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.

Authors:  Louis J Dell'Italia; James F Collawn; Carlos M Ferrario
Journal:  Circ Res       Date:  2018-01-19       Impact factor: 17.367

Review 7.  Proteases in Pemphigoid Diseases.

Authors:  Sho Hiroyasu; Christopher T Turner; Katlyn C Richardson; David J Granville
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.